clarithromycin has been researched along with Bacterial Infections, Gram-Negative in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (28.57) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 6 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baudry, PJ; DeCorby, M; Hoban, DJ; Johnson, J; Karlowsky, JA; Lagacé-Wiens, P; Laing, N; McCracken, M; Mulvey, MR; Nichol, KA; Tailor, F; Vashisht, R; Walkty, A; Weshnoweski, B; Wierzbowski, A; Zhanel, GG | 1 |
| Akyüz, S; Aşker, S; Baran, Aİ; Ekin, S; Özgökçe, M; Sünnetçioğlu, A; Turgut, E; Üney, İ; Yildiz, H | 1 |
| Huang, E; Meeker, DG; Moon, SH; Smeltzer, MS; Zhang, X; Zheng, G | 1 |
| Karagouni, AD; Pangalis, A; Papaparaskevas, J; Sawides, AL; Serelis, J; Stathi, A; Tsakris, A | 1 |
| Antonopoulou, A; Armaganidis, A; Baziaka, F; Douzinas, EE; Georgopoulou, AP; Giamarellos-Bourboulis, EJ; Gogos, C; Kanni, T; Kopterides, P; Koratzanis, G; Kotsaki, A; Koutelidakis, I; Koutoukas, P; Ladas, M; Lymberopoulou, K; Maniatis, N; Marioli, A; Mouktaroudi, M; Mylona, V; Papadomichelakis, E; Papageorgiou, C; Papaziogas, B; Pelekanos, N; Pelekanou, A; Raftogiannis, M; Savva, A; Spyridaki, A; Tsaganos, T; Tsangaris, I; Vaki, I | 1 |
| Ali-Dinar, T; Colin, AA | 1 |
| Hsieh, CJ; Hsueh, PR; Hwang, KP; Kuo, KC | 1 |
| Bodasing, N; Kennedy, D | 1 |
| Ferguson, BJ | 1 |
| Dudler, J; Gerster, JC | 1 |
| Anagnostopoulou, M; Boulbasakos, G; Paniara, O; Pirounaki, M; Platsouka, E; Raptis, J; Saroglou, G; Sioula, E; Tatsis, G; Tsoukalas, G | 1 |
| Lipsky, BA; Talbot, GH; Townsend, L; Unowsky, J; Zhang, H | 1 |
| Iakovlev, VP | 1 |
| Tunkel, AR; Whitman, MS | 1 |
2 review(s) available for clarithromycin and Bacterial Infections, Gram-Negative
| Article | Year |
|---|---|
[New semisynthetic macrolides. Clarithromycin--its importance in the current therapy of bacterial infections].
Topics: Anti-Bacterial Agents; Clarithromycin; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Tissue Distribution | 1999 |
Azithromycin and clarithromycin: overview and comparison with erythromycin.
Topics: Azithromycin; Bacterial Infections; Clarithromycin; Erythromycin; Gram-Negative Bacterial Infections; Humans; In Vitro Techniques; Mycobacterium Infections, Nontuberculous; Respiratory Tract Infections; Sexually Transmitted Diseases; Skin Diseases, Infectious | 1992 |
3 trial(s) available for clarithromycin and Bacterial Infections, Gram-Negative
| Article | Year |
|---|---|
Effect of clarithromycin in patients with suspected Gram-negative sepsis: results of a randomized controlled trial.
Topics: Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Double-Blind Method; Female; Gram-Negative Bacterial Infections; Health Care Costs; Humans; Male; Middle Aged; Placebos; Prospective Studies; Sepsis; Survival Analysis; Treatment Outcome; Young Adult | 2014 |
Efficacy and tolerance of roxithromycin versus clarithromycin in the treatment of lower respiratory tract infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Respiratory Tract Infections; Roxithromycin | 1998 |
Treating acute bacterial exacerbations of chronic bronchitis in patients unresponsive to previous therapy: sparfloxacin versus clarithromycin.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Antitubercular Agents; Bronchitis; Chronic Disease; Clarithromycin; Double-Blind Method; Female; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged | 1999 |
9 other study(ies) available for clarithromycin and Bacterial Infections, Gram-Negative
| Article | Year |
|---|---|
Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; Canada; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Population Surveillance | 2008 |
Delftia acidovorans pneumonia with lung cavities formation.
Topics: Anti-Bacterial Agents; Clarithromycin; Delftia acidovorans; Female; Gram-Negative Bacterial Infections; Humans; Immunocompromised Host; Lung; Middle Aged; Piperacillin, Tazobactam Drug Combination; Pneumonia, Bacterial; Tomography, X-Ray Computed | 2019 |
Novel Linear Lipopeptide Paenipeptins with Potential for Eradicating Biofilms and Sensitizing Gram-Negative Bacteria to Rifampicin and Clarithromycin.
Topics: Anti-Bacterial Agents; Biofilms; Clarithromycin; Drug Synergism; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hemolysis; Humans; Lipopeptides; Microbial Sensitivity Tests; Paenibacillus; Rifampin; Structure-Activity Relationship | 2017 |
Granulomatous infection of the hand and wrist due to Azospirillum spp.
Topics: Anti-Bacterial Agents; Azospirillum; Clarithromycin; Female; Gram-Negative Bacterial Infections; Granuloma; Humans; Microbial Sensitivity Tests; Middle Aged; Tenosynovitis; Wrist | 2013 |
Aerosolized amikacin and oral clarithromycin to eradicate Mycobacterium abscessus in a patient with cystic fibrosis: an 8-year follow-up.
Topics: Administration, Oral; Adult; Amikacin; Anti-Bacterial Agents; Clarithromycin; Cystic Fibrosis; Drug Therapy, Combination; Female; Forced Expiratory Volume; Gram-Negative Bacterial Infections; Humans; Mycobacterium; Mycobacterium Infections; Nebulizers and Vaporizers; Pseudomonas aeruginosa; Pseudomonas Infections; Stenotrophomonas maltophilia | 2010 |
Facial cellulitis because of Aggregatibacter (Actinobacillus) actinomycetemcomitans and Capnocytophaga species in an immunocompetent patient.
Topics: Actinobacillus Infections; Administration, Oral; Adolescent; Aggregatibacter actinomycetemcomitans; Amikacin; Capnocytophaga; Cellulitis; Clarithromycin; Face; Female; Gram-Negative Bacterial Infections; Humans | 2011 |
Moraxella catarrhalis bacteraemia associated with Mycoplasma pneumoniae infection and pneumonia.
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteremia; Breast Neoplasms; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Female; Gram-Negative Bacterial Infections; Humans; Moraxella catarrhalis; Mycoplasma pneumoniae; Pneumonia, Mycoplasma | 2002 |
Is it spontaneous resolution or macrolide efficacy?
Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Chronic Disease; Clarithromycin; Female; Gram-Negative Bacterial Infections; Humans; Infant; Macrolides; Male; Microbial Sensitivity Tests; Moraxella catarrhalis; Nasopharynx; Otitis Media with Effusion; Pneumococcal Infections; Rhinitis; Sinusitis; Streptococcus pneumoniae | 2004 |
Cellulitis caused by Capnocytophaga cynodegmi associated with etanercept treatment in a patient with rheumatoid arthritis.
Topics: Animals; Anti-Bacterial Agents; Antirheumatic Agents; Arthritis, Rheumatoid; Bites and Stings; Capnocytophaga; Cats; Cellulitis; Clarithromycin; Etanercept; Female; Gram-Negative Bacterial Infections; Humans; Immunocompromised Host; Immunoglobulin G; Middle Aged; Receptors, Tumor Necrosis Factor; Treatment Outcome | 2004 |